IM Cannabis Has Decided Not To Make Remaining Installment Payments Installments By IMC Holdings Ltd., And As Such Will Transfer The 51% Shares Held By IMC Holdings Ltd Back To The Seller
IM Cannabis Has Decided Not To Make Remaining Installment Payments Installments By IMC Holdings Ltd., And As Such Will Transfer The 51% Shares Held By IMC Holdings Ltd Back To The Seller
IM Cannabis Corp. (CSE:IMCC) (NASDAQ:IMCC) (the "Company" or "IMC"), a leading medical cannabis company with operations in Israel and Germany, is announcing that, further to the news release dated January 12, 2024, the Company has decided not to make remaining installment payments installments (i.e. NIS 5,873K including interest or 2,154K CAD) by IMC Holdings Ltd., and as such will transfer the 51% shares held by IMC Holdings Ltd back to the seller.
在以色列和德國開展業務的領先醫用大麻公司 IM Cannabis Corp.（CSE: IMCC）（納斯達克股票代碼：IMCC）（“公司” 或 “IMC”）宣佈，繼2024年1月12日的新聞稿之後，該公司決定不向IMC Holdings Ltd分期支付剩餘的分期付款（即含利息的5,873K新謝克爾或2,154萬加元），因此將將IMC控股有限公司持有的51％的股份轉讓給賣方。
"With the April 1st cannabis legalization in Germany, we are focusing our resources on the German market, where we expect to see the biggest growth potential," said Oren Shuster, CEO of IMC. "With both of our core markets, Germany and Israel, currently undergoing rapid evolution, we need to assure that we allocate our resources to the growth opportunities where we expect the best return on investment."
IMC首席執行官奧倫·舒斯特表示：“隨着4月1日德國大麻合法化，我們將資源集中在德國市場，我們預計德國市場將呈現最大的增長潛力。”“由於我們的兩個核心市場德國和以色列目前都在快速發展，我們需要確保將資源分配給我們期望獲得最佳投資回報的增長機會。”